Business Context and Reporting Period
Company: John B. Sanfilippo & Son, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Quarter and twenty-six weeks ended December 25, 2003 (Fiscal 2004).
Business Overview: The Company processes, packages, markets, and distributes shelled and in-shell nuts, peanut butter, candy, and snack items. It sells to consumer, industrial, food service, contract packaging, and export markets under private labels and the Fisher brand.
Key Financial Metrics
| Metric (in thousands) | Quarter Ended Dec 25, 2003 |
Quarter Ended Dec 26, 2002 |
26 Weeks Ended Dec 25, 2003 |
26 Weeks Ended Dec 26, 2002 |
|---|---|---|---|---|
| Net Sales | $171,392 | $138,107 | $296,153 | $233,434 |
| Gross Profit | $33,219 | $26,429 | $58,712 | $39,729 |
| Gross Margin % | 19.4% | 19.1% | 19.8% | 17.0% |
| Income from Operations | $17,864 | $14,483 | $30,483 | $18,301 |
| Net Income | $10,449 | $8,243 | $17,611 | $9,921 |
| Diluted EPS | $1.09 | $0.89 | $1.85 | $1.07 |
| Cash from Operations (26 wks) | $22,838 (2003) vs $18,802 (2002) | |||
| Total Debt (Current + Long-Term) | $52,329 (Dec 25, 2003) | |||
| Cash & Equivalents | $1,764 (Dec 25, 2003) |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 24.1% for the quarter and 26.9% for the twenty-six weeks, driven primarily by unit volume increases across all distribution channels (Consumer, Industrial, Export, Food Service) and higher selling prices for pecans.
- Profitability: Net income rose 26.8% for the quarter and 77.5% for the twenty-six weeks. Gross margins improved due to lower peanut costs (following the termination of the federal peanut quota program), volume leverage on fixed costs, and favorable adjustments to pecan inventory.
- Expenses: Selling and administrative expenses increased as a percentage of sales, largely due to higher employee incentive compensation tied to improved results and increased legal/professional fees related to the DOJ antitrust investigation and Sarbanes-Oxley compliance.
- Balance Sheet: Inventories increased to $139.9 million (from $112.0 million at June 26, 2003) due to seasonal purchasing and higher finished goods to support sales volume. Accounts receivable rose to $50.3 million, reflecting seasonal sales peaks.
- Restatement: Financial statements were restated to reclassify freight costs from a reduction in net sales to selling expenses (per EITF 00-10). This increased reported net sales and selling expenses but had no impact on net income or cash flows.
Guidance, Outlook, and Risks
- Outlook: Management expects continued demand growth driven by health trends (low carbohydrate/high protein diets). However, Chicago area facilities are operating at full capacity; a potential consolidation project (4-5 years) could cause disruptions or cost overruns.
- Raw Materials: The Company does not hedge against commodity price fluctuations. Profitability is sensitive to crop yields, weather, and market prices for peanuts, pecans, and other nuts. Significant inventory holdings expose the Company to market price declines.
- Regulatory & Legal:
- Antitrust Investigation: The Company is a subject of an ongoing DOJ investigation into the peanut shelling industry regarding procurement pricing practices.
- Bioterrorism Act: New FDA regulations regarding food safety and import prior notice could disrupt the supply of imported nuts (approx. 37% of purchases).
- Fixed Price Commitments: Approximately 15-20% of annual sales are fixed-price commitments. If acquisition costs rise after these commitments are made, the Company may incur losses.
Investor Verification Checklist
- Restatement Impact: Verify the specific dollar amount of freight costs reclassified to selling expenses to ensure accurate margin comparisons with peers.
- Inventory Valuation: Confirm the valuation of the $139.9 million inventory, particularly inshell pecans, given the risk of market price fluctuations and the estimation methods used for bulk weighing.
- Antitrust Exposure: Monitor updates on the DOJ investigation to assess potential fines, penalties, or operational restrictions.
- Capacity Constraints: Evaluate the timeline and capital requirements for the proposed facility consolidation to determine if growth targets are achievable without disruption.
- Debt Covenants: Review compliance with restrictive covenants, specifically those limiting dividends and capital expenditures, given the company's leverage and planned capital projects.